Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Pathology International

Volumn 61, Issue 9, 2011, Pages 518-527

  Mii, Akiko ^a   Shimizu, Akira ^a   Kaneko, Tomohiro ^a   Fujita, Emiko ^a   Fukui, Megumi ^a   Fujino, Teppei ^a   Utsumi, Kouichi ^a   Yamaguchi, Hiroki ^a   Tajika, Kenji ^a   Tsuchiya, Shin Ichi ^b   Iino, Yasuhiko ^a   Katayama, Yasuo ^a   Fukuda, Yuh ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

Author keywords

C4d; Chronic GVHD; Chronic humoral GVHD; Hematopoietic stem cell transplantation; Kidney; Thrombotic microangiopathy

Indexed keywords

COMPLEMENT COMPONENT C4D;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOPSY; CAPILLARITIS; CASE REPORT; CD3+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; GLOMERULITIS; GLOMERULUS CAPILLARY; GLOMERULUS EPITHELIUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY THROMBOTIC MICROANGIOPATHY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ARTERIOLES; AUTOPSY; BIOPSY; COMPLEMENT C4B; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; THROMBOTIC MICROANGIOPATHIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 80052259769     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02704.x     Document Type: Article

References (42)

1. Hingorani SR, Guthrie K, Batchelder A etal. Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors. Kidney Int 2005; 67: 272-7.
2. Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int 2006; 69: 430-35.
3. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: Epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 2006; 17: 1995-2005.
4. Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007; 39: 223-9.
5. Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD. Chronic kidney disease after hematopoietic cell transplantation: A systematic review. Am J Transplant 2008; 8: 2378-90.
6. Terrier B, Delmas Y, Hummel A etal. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: Clinical presentation, outcome and pathogenic aspects. Nephrol Dial Transplant 2007; 22: 1369-76.
7. Chang A, Hingorani S, Kowalewska J etal. Spectrum of renal pathology in hematopoietic cell transplantation: A series of 20 patients and review of the literature. Clin J Am Soc Nephrol 2007; 2: 1014-23.
8. Troxell ML, Pilapil M, Miklos DB, Higgins JP, Kambham N. Renal pathology in hematopoietic cell transplantation recipients. Mod Pathol 2008; 21: 396-406.
9. Chan GS, Lam MF, Au WY etal. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation. Nephrology (Carlton) 2008; 13: 322-30.
10. Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: Role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009; 4: 345-53.
11. Sale GE, Shulman HM, Hackman RC. Transplantation: Bone marrow. In: Colvin RB, Bhan AK, MacCluskey RT, eds. Diagnostic Immunopathology, 2nd edn. New York: Raven Press, 1995; 435-53.
12. Baird K, Pavletic SZ. Chronic graft versus host disease. Curr Opin Hematol 2006; 13: 426-35.
13. Narimatsu H, Miyakoshi S, Yamaguchi T etal. Chronic graft-versus-host disease following umbilical cord blood transplantation: Retrospective survey involving 1072 patients in Japan. Blood 2008; 112: 2579-82.
14. Otani M, Shimojo H, Shiozawa S, Shigematsu H. Renal involvement in bone marrow transplantation. Nephrology (Carlton) 2005; 10: 530-36.
15. Reddy P, Johnson K, Uberti JP etal. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 351-7.
16. Kusumi E, Kami M, Hara S etal. Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: Possible involvement of graft-versus-host disease. Int J Hematol 2008; 87: 225-30.
17. Mii A, Shimizu A, Masuda Y etal. Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation. Pathol Int 2011; 61: 34-41.
18. Racusen LC, Solez K, Colvin RB etal. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-23.
19. Solez K, Colvin RB, Racusen LC etal. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-26.
20. Solez K, Colvin RB, Racusen LC etal. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-60.
21. Kojouri K, George JN. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 2007; 19: 148-54.
22. Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: An autopsy study. Transplantation 2008; 85: 22-8.
23. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting? Bone Marrow Transplant 2007; 40: 709-19.
24. Choi CM, Schmaier AH, Snell MR, Lazarus HM. Thrombotic microangiopathy in haematopoietic stem cell transplantation: Diagnosis and treatment. Drugs 2009; 69: 183-98.
25. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-56.
26. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003; 54: 29-52.
27. Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol 2004; 125: 435-54.
28. Filipovich AH, Weisdorf D, Pavletic S etal. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-56.
29. Talmadge JE. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Int Immunopharmacol 2003; 3: 1121-43.
30. Sun Y, Tawara I, Toubai T, Reddy P. Pathophysiology of acute graft-versus-host disease: Recent advances. Transl Res 2007; 150: 197-214.
31. Biedermann BC, Sahner S, Gregor M etal. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 2002; 359: 2078-83.
32. Kanamori H, Maruta A, Sasaki S etal. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 1998; 21: 705-9.
33. Matsuda Y, Hara J, Osugi Y etal. Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplant 2001; 27: 977-82.
34. Kapur R, Ebeling S, Hagenbeek A. B-cell involvement in chronic graft-versus-host disease. Haematologica 2008; 93: 1702-11.
35. Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS. The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009; 114: 4919-27.
36. Alousi AM, Uberti J, Ratanatharathorn V. The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant. Leuk Lymphoma 2010; 51: 376-89.
37. Au WY, Ma ES, Lee TL etal. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol 2007; 137: 475-8.
38. Kayler LK, Kiss L, Sharma V etal. Acute renal allograft rejection: Diagnostic significance of focal peritubular capillary C4d. Transplantation 2008; 85: 813-20.
39. Kedainis RL, Koch MJ, Brennan DC, Liapis H. Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival. Am J Transplant 2009; 9: 812-9.
40. Einecke G, Sis B, Reeve J etal. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-31.
41. Sis B, Mengel M, Haas M etal. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of banff working groups. Am J Transplant 2010; 10: 464-71.
42. Sijpkens YW, Joosten SA, Wong MC etal. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 2409-18.